Home › Diabetic Kidney Problems › Texas › San Antonio
Diabetic Kidney Problems clinical trials in San Antonio, TX
4 studies for Diabetic Kidney Problems are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
RecruitingPhase 1Healthy volunteers welcome
- Research Site, San Antonio
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Clinical Advancement Center, San Antonio
- University of Texas Health - San Antonio, San Antonio
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2
- Clinical Advancement Center, San Antonio
Transformative Research in Diabetic Nephropathy
RecruitingObservational study
- University of Texas Health Science Center at San Antonio, San Antonio
About Diabetic Kidney Problems
Diabetes is the most common cause of kidney failure in the U.S. Kidney damage from Diabetes is called Diabetic Nephropathy.
More about Diabetic Kidney Problems on MedlinePlus
Diabetic Kidney Problems trials in other cities
- Seattle, WA5 studies
- Chicago, IL4 studies
- Spokane, WA3 studies
- Philadelphia, PA3 studies
- New York City, NY3 studies
- Aurora, CO3 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer45 studies
- Metastatic Cancer44 studies
- Colorectal Cancer43 studies
- Cancer (all types)41 studies
- Obesity39 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer33 studies
- Pancreatic Cancer33 studies
- Lung Cancer27 studies
- Prostate Cancer27 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.